Nautilus Biotechnology, Inc. (NAUT) Tops Q3 EPS by 8c

Nautilus Biotechnology, Inc. (NASDAQ: NAUT) reported Q3 EPS of ($0.11), $0.08 better than the analyst estimate of ($0.19).

For earnings history and earnings-related data on Nautilus Biotechnology, Inc. (NAUT) click here.

You May Also Be Interested In

• Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
• Leerink Starts Nautilus Biotechnology (NAUT) at Outperform
• RH (RH) Tops Q2 EPS by $2.31